Study of SON-1010 (IL12-FHAB) in Healthy Adults
Clinical trial NCT05408572 · COMPLETED
Trial details
- NCT number
- NCT05408572
- Sponsor
- Sonnet BioTherapeutics
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-27
- Primary completion
- 2023-02-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.